findmyKOL

Ralph Defronzo, MD

Enriched profile

Professor of Medicine; Chief, Diabetes Division; Deputy Director, Texas Diabetes Institute · UT Health San Antonio

ORCIDNPI
Region🇺🇸 San Antonio, TX · South Central · United StatesSpecialtyEndocrinology, Diabetes & MetabolismFocusDiabetes Treatment and Management+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2026Online presenceverified 2026Payments2021–2025NIH funding1988–2026

Ralph Defronzo is Professor of Medicine; Chief, Diabetes Division; Deputy Director, Texas Diabetes Institute at UT Health San Antonio. OpenAlex indexes 407 publications with 52,161 citations (h-index 99); ClinicalTrials.gov lists 27 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 1% of Endocrinology, Diabetes & Metabolism profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Ralph A. DeFronzo, MD, is Professor of Medicine at UT Health San Antonio (Long School of Medicine). The public record shows 407 publications with 52,161 citations (h-index 99), centered on Diabetes Treatment and Management, Metabolism, Diabetes, and Cancer, Diabetes, Cardiovascular Risks, and Lipoproteins. It also documents an investigator role on 27 registered clinical trials, industry payments reported by 23 companies, 9 NIH-funded awards (1988–2026).

  • Most recent indexed publication: 2026 · Diabetes care
  • Top research focus: Diabetes Treatment and Management
  • 27 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 23 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Type 2 Diabetes19 trialsInsulin Resistance4 trialsHeart Failure3 trialsGlucose Intolerance2 trialsMitochondrial Diseases1 trialMultiple Mitochondrial Dysfunctions Syndrome1 trialCoronary Artery Disease / ACS1 trialHypoglycemia1 trialType 1 Diabetes1 trialGlucose Metabolism Disorders1 trialCOVID-191 trial

Research focus

OpenAlex concept fingerprint
Diabetes Treatment and ManagementMetabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and LipoproteinsPancreatic function and diabetesDiabetes Management and Research

Drugs & molecules

across trials, industry payments and publications
Farxigageneric · DapagliflozinClinical trialsIndustry payments61Publications3Kerendiageneric · FinerenoneClinical trialsIndustry payments8Publications1Jardiancegeneric · EmpagliflozinClinical trialsIndustry payments3Publications4

Works with

trial sponsors and companies reporting payments
AstraZeneca Pharmaceuticals LPClinical trialsIndustry payments79Corcept TherapeuticsClinical trialsIndustry payments73Novo Nordisk IncClinical trialsIndustry payments43

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
407publications

Distinct works indexed by OpenAlex, matched via ORCID; 33 in PubMed.

52,161citations

Total citations across indexed works.

99h-index

Hirsch index (OpenAlex). i10-index 261.

Clinical & industry

trials, payments and federal funding
27clinical trials

Investigator role on registered studies.

View trials
23companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
9NIH grants · 1988–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 27 registered studies on ClinicalTrials.gov. The most recent:

24 more trial records behind the reveal.Reveal →

Industry payments

Updated 27 Aug 2026

23 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2019)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Hormonal (systemic)

    100%
    l-Thyroxine100%
    Levothyroxine Sodium100%
    Part D<11 patients

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

9 NIH research awards on record, funded 19882026 per NIH RePORTER. The latest:

Congress activity

Updated 27 Aug 2026

9 congress contributions (2009–2025) across AACE, ADA, ASH, ENDO per OpenAlex. The most recent:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Owned accounts

public accounts run by this person
  • Doximity

    doximity.com/pub/ralph-defronzo-md

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com
  • LinkedIn

    linkedin.com/in/ralph-defronzo-4a56b8269

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com
  • Other

    directory.uthscsa.edu/academics/profile/defronzo

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu
2 more verified accounts behind the reveal.Reveal →

Mentions by others

where others cite or feature them
  • Other

    vumedi.com/channel/dr-ralph-defronzo/tab/videos-1536/video/obesity-and-diabetes-qa-panel-discussion

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vumedi.com
  • X / Twitter

    x.com/asnpublications/status/1986146508232654997

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →x.com
  • Spotify

    open.spotify.com/episode/3S7LUVjBuJtgtinyAUSrX1

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →open.spotify.com
7 more mentions behind the reveal.Reveal →

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD (Cum Laude)

    Harvard Medical School

    1969
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu
  • MS in Medicine (Cum Laude)

    Boston College Graduate School

    1969
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu
  • BS

    Biology/Biochemistry, Yale University

    1964
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu
  • Board Certified

    Internal Medicine and Nephrology (American Board of Internal Medicine)

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu
  • Postdoctoral Fellowship in Endocrinology

    NIH/Baltimore City Hospital

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu
  • Postdoctoral Fellowship in Nephrology

    Hospital of the University of Pennsylvania

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →directory.uthscsa.edu

Editorial & leadership roles

journal and society appointments

Awards & honors

honors on the public record
5 more awards behind the reveal.Reveal →

Secondary affiliations

appointments beyond the home institution
  • Deputy Director

    Texas Diabetes Institute, University Health System, San Antonio, TX

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.uthscsa.edu
  • Holder

    Joe R. and Teresa Lozano Long Distinguished Chair in Diabetes

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →news.uthscsa.edu

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.